Cargando…

Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines

Immunotherapy for treating IgE-mediated allergies requires high doses of the corresponding allergen. This may result in undesired side effects and, to avoid them, hypoallergenic allergens (allergoids) polymerized with glutaraldehyde are commonly used. Targeting allergoids to dendritic cells to enhan...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzano, Ana I., Javier Cañada, F., Cases, Bárbara, Sirvent, Sofia, Soria, Irene, Palomares, Oscar, Fernández-Caldas, Enrique, Casanovas, Miguel, Jiménez-Barbero, Jesús, Subiza, José L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722057/
https://www.ncbi.nlm.nih.gov/pubmed/26603537
http://dx.doi.org/10.1007/s10719-015-9640-4
_version_ 1782411311504687104
author Manzano, Ana I.
Javier Cañada, F.
Cases, Bárbara
Sirvent, Sofia
Soria, Irene
Palomares, Oscar
Fernández-Caldas, Enrique
Casanovas, Miguel
Jiménez-Barbero, Jesús
Subiza, José L.
author_facet Manzano, Ana I.
Javier Cañada, F.
Cases, Bárbara
Sirvent, Sofia
Soria, Irene
Palomares, Oscar
Fernández-Caldas, Enrique
Casanovas, Miguel
Jiménez-Barbero, Jesús
Subiza, José L.
author_sort Manzano, Ana I.
collection PubMed
description Immunotherapy for treating IgE-mediated allergies requires high doses of the corresponding allergen. This may result in undesired side effects and, to avoid them, hypoallergenic allergens (allergoids) polymerized with glutaraldehyde are commonly used. Targeting allergoids to dendritic cells to enhance cell uptake may result in a more effective immunotherapy. Allergoids coupled to yeast mannan, as source of polymannoses, would be suitable for this purpose, since mannose-binding receptors are expressed on these cells. Conventional conjugation procedures of mannan to proteins use oxidized mannan to release reactive aldehydes able to bind to free amino groups in the protein; yet, allergoids lack these latter because their previous treatment with glutaraldehyde. The aim of this study was to obtain allergoids conjugated to mannan by an alternative approach based on just glutaraldehyde treatment, taking advantage of the mannoprotein bound to the polymannose backbone. Allergoid-mannan glycoconjugates were produced in a single step by treating with glutaraldehyde a defined mixture of allergens derived from Phleum pratense grass pollen and native mannan (non-oxidized) from Saccharomyces cerevisae. Analytical and structural studies, including 2D-DOSY and (1)H-(13)C HSQC nuclear magnetic resonance spectra, demonstrated the feasibility of such an approach. The glycoconjugates obtained were polymers of high molecular weight showing a higher stability than the native allergen or the conventional allergoid without mannan. The allergoid-mannan glycoconjugates were hypoallergenic as detected by the IgE reactivity with sera from grass allergic patients, even with lower reactivity than conventional allergoid without mannan. Thus, stable hypoallergenic allergoids conjugated to mannan suitable for using in immunotherapy can be achieved using glutaraldehyde. In contrast to mannan oxidation, the glutaraldehyde approach allows to preserve mannoses with their native geometry, which may be functionally important for its receptor-mediated recognition.
format Online
Article
Text
id pubmed-4722057
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-47220572016-02-01 Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines Manzano, Ana I. Javier Cañada, F. Cases, Bárbara Sirvent, Sofia Soria, Irene Palomares, Oscar Fernández-Caldas, Enrique Casanovas, Miguel Jiménez-Barbero, Jesús Subiza, José L. Glycoconj J Original Article Immunotherapy for treating IgE-mediated allergies requires high doses of the corresponding allergen. This may result in undesired side effects and, to avoid them, hypoallergenic allergens (allergoids) polymerized with glutaraldehyde are commonly used. Targeting allergoids to dendritic cells to enhance cell uptake may result in a more effective immunotherapy. Allergoids coupled to yeast mannan, as source of polymannoses, would be suitable for this purpose, since mannose-binding receptors are expressed on these cells. Conventional conjugation procedures of mannan to proteins use oxidized mannan to release reactive aldehydes able to bind to free amino groups in the protein; yet, allergoids lack these latter because their previous treatment with glutaraldehyde. The aim of this study was to obtain allergoids conjugated to mannan by an alternative approach based on just glutaraldehyde treatment, taking advantage of the mannoprotein bound to the polymannose backbone. Allergoid-mannan glycoconjugates were produced in a single step by treating with glutaraldehyde a defined mixture of allergens derived from Phleum pratense grass pollen and native mannan (non-oxidized) from Saccharomyces cerevisae. Analytical and structural studies, including 2D-DOSY and (1)H-(13)C HSQC nuclear magnetic resonance spectra, demonstrated the feasibility of such an approach. The glycoconjugates obtained were polymers of high molecular weight showing a higher stability than the native allergen or the conventional allergoid without mannan. The allergoid-mannan glycoconjugates were hypoallergenic as detected by the IgE reactivity with sera from grass allergic patients, even with lower reactivity than conventional allergoid without mannan. Thus, stable hypoallergenic allergoids conjugated to mannan suitable for using in immunotherapy can be achieved using glutaraldehyde. In contrast to mannan oxidation, the glutaraldehyde approach allows to preserve mannoses with their native geometry, which may be functionally important for its receptor-mediated recognition. Springer US 2015-11-25 2016 /pmc/articles/PMC4722057/ /pubmed/26603537 http://dx.doi.org/10.1007/s10719-015-9640-4 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Manzano, Ana I.
Javier Cañada, F.
Cases, Bárbara
Sirvent, Sofia
Soria, Irene
Palomares, Oscar
Fernández-Caldas, Enrique
Casanovas, Miguel
Jiménez-Barbero, Jesús
Subiza, José L.
Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines
title Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines
title_full Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines
title_fullStr Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines
title_full_unstemmed Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines
title_short Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines
title_sort structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722057/
https://www.ncbi.nlm.nih.gov/pubmed/26603537
http://dx.doi.org/10.1007/s10719-015-9640-4
work_keys_str_mv AT manzanoanai structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines
AT javiercanadaf structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines
AT casesbarbara structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines
AT sirventsofia structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines
AT soriairene structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines
AT palomaresoscar structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines
AT fernandezcaldasenrique structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines
AT casanovasmiguel structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines
AT jimenezbarberojesus structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines
AT subizajosel structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines